Welcome to LookChem.com Sign In|Join Free
  • or
4-(oxazol-4-yl)benzonitrile is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

620971-46-2

Post Buying Request

620971-46-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

620971-46-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 620971-46-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,0,9,7 and 1 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 620971-46:
(8*6)+(7*2)+(6*0)+(5*9)+(4*7)+(3*1)+(2*4)+(1*6)=152
152 % 10 = 2
So 620971-46-2 is a valid CAS Registry Number.

620971-46-2Relevant academic research and scientific papers

Charge Transport and Quantum Interference Effects in Oxazole-Terminated Conjugated Oligomers

Li, Songsong,Yu, Hao,Schwieter, Kenneth,Chen, Kejia,Li, Bo,Liu, Yun,Moore, Jeffrey S.,Schroeder, Charles M.

, p. 16079 - 16084 (2019)

Charge transport in single molecule junctions critically depends on the chemical identity of anchor groups used to connect molecular wires to electrodes. In this work, we report the charge transport properties of conjugated oligomers with oxazole anchors,

4-(IMIDAZO[1,2-A]PYRIDIN-3-YL) -PYRIMIDINE DERIVATIVES

-

Page/Page column 89, (2021/01/29)

Compounds of the formula (I) in which R1, R2, V, X, Y and Z have the meanings indicated in Claim 1, are inhibitors of c-Kit kinase, and can be employed for the treatment of cancer.

Oxazolidone derivatives as PR modulators

-

Page/Page column 37, (2008/06/13)

Compounds of the following structure are described: wherein R1, R2, R5, R6, V, X, Y, Z and Q are described herein, or a pharmaceutically acceptable salt, tautomer, metabolite or prodrug thereof. These compounds are useful for treating a variety of hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake or synchronizing estrus.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 620971-46-2